

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Lipase ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XEN445 |
+++
endothelial lipase, IC50: 0.237 μM |
99%+ | |||||||||||||||||
| JZL184 |
++++
MAGL, IC50: 8 nM |
98% | |||||||||||||||||
| Tanshinone IIA | ✔ | 97% | |||||||||||||||||
| Orlistat | ✔ | 98% | |||||||||||||||||
| Atglistatin |
++
ATGL, IC50: 0.7 μM |
99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | XEN445 is a potent and selective endothelial lipase inhibitor with IC50 of 0.237 μM. |
| Concentration | Treated Time | Description | References | |
| MDA-MB-468 cells | 200 µM | 30 minutes | XEN445 significantly inhibited PLA1 activity in LIPG-overexpressing MDA-MB-468 cells by approximately 80% | Sci Rep. 2020 Jun 2;10(1):8911 |
| MCF7 and T47D cells | 200 and 250 µM | 4 days | XEN445 selectively reduced the viability of LIPG-expressing TNBC cells but had no significant effect on LIPG-deficient LuBC cells | Sci Rep. 2020 Jun 2;10(1):8911 |
| MCF10DCIS cells | 1 to 200 µM | 4 days | XEN445 (≥100 μM) significantly inhibited the viability of MCF10DCIS cells | Sci Rep. 2020 Jun 2;10(1):8911 |
| Administration | Dosage | Frequency | Description | References | ||
| Nude mice | MDA-MB-468 xenograft model | Intraperitoneal injection | 50 mg/kg | Three times per week for 32 days | XEN445 significantly inhibited the growth of MDA-MB-468 xenograft tumors, reduced the number of Ki67-positive cells, but had no significant impact on the EMT phenotype of the tumors | Sci Rep. 2020 Jun 2;10(1):8911 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.73mL 0.55mL 0.27mL |
13.65mL 2.73mL 1.36mL |
27.30mL 5.46mL 2.73mL |
|
| CAS号 | 1515856-92-4 |
| 分子式 | C18H17F3N2O3 |
| 分子量 | 366.33 |
| SMILES Code | O=C(C1=CC(C(F)(F)F)=CC=C1N2C[C@H](CC2)OCC3=NC=CC=C3)O |
| MDL No. | MFCD28166367 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | NBGRERFNOKZQLO-AWEZNQCLSA-N |
| Pubchem ID | 72736173 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 40 mg/mL(109.19 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
沪公网安备 31011702889066号
沪ICP备2024050318号-1